adcs for the treatment of her2-low breast cancer
Published 2 years ago • 385 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
6:51
adcs for her2 and her2-low breast cancer
-
1:35
advances in novel adcs for her2-expressing breast cancer
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
1:09
the exciting new field of her2-low breast cancer
-
1:24
novel treatment options for her2-low breast cancer
-
1:10
do adcs have a future in treating breast cancer?
-
53:15
will new antibody drug conjugates cure bladder cancer?
-
5:16
treatment options for her2-low breast cancer: all you need to know
-
0:56
remaining questions on the management of her2-low breast cancer
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
0:46
what does the future hold for adcs in breast cancer?
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
1:36
is her2-low a distinct subtype of breast cancer?
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
54:43
the science of her2-low breast cancer and implications for the pathology team
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal